Study shows ulcerative colitis patients achieve remission with probiotic composition VSL#3
A multi-center study found that 63% of patients with mild to moderate ulcerative colitis achieved remission after taking four packets of VSL#3 daily for six weeks. The probiotic composition demonstrated safety and efficacy in patients not responding to conventional therapies.